Elevate global medical affairs strategy and execution for innovative therapies in psoriatic disease. Collaborate across regions to drive clinical-commercial optimization and influence transformational medicine development and patient care.

Lead the charge in advancing dermatology medical affairs initiatives by contributing to Phase IIIb & IV trials, protocol development, and real-world evidence strategy, influencing the future of immunological treatments and patient care.